• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

D.Western Therapeutics Institute Inc

+ Add to Watchlist

6DW:GR

10.800 EUR 0.265 2.39%

As of 02:08:11 ET on 09/19/2014.

Snapshot for D.Western Therapeutics Institute Inc (6DW)

Open: 11.520 Day's Range: 10.800 - 11.520 Volume: 0
Previous Close: 11.065 52wk Range: 3.632 - 1,000.000 1-Yr Rtn: +63.64%

Stock Chart for 6DW

No chart data available.
  • 6DW:GR 11.520
  • 1D
  • 1M
  • 1Y
11.065
Interactive 6DW Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 6DW

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (JPY) (ttm) -
Est. EPS (JPY) (12/2014) -
Est. PEG Ratio -
Market Cap (M EUR) 245.88
Shares Outstanding (M) 22.77
30 Day Average Volume 47
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/13/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 6DW

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 6DW

D.Western Therapeutics Institute Inc.(DWTI) is a biotechnology (bio-venture) company that focuses on development of new drugs. The Company's focus is on protein kinase inhibitors. DWTI discovers and develops several drugs, such as antiglaucoma, antihypertensive, neuroprotective, antithrombogenic, antiatherosclerosis and anticancer.

Hiroyoshi HidakaChairman/Chief Scientist OfcrYuichi HidakaPresident/CEO
Ayako KamikuboDirectorMasakatsu NishikawaDirector
More Company Profile & Key Executives for 6DW

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil